Andrew J. Einhorn

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Durham, NC
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Andrew J. Einhorn
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Andrew J. Einhorn

Form 4 holding Chief Financial Officer

RVL Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
141,473
Estimated value
$4,414
Report date
24 Jan 2022
Price
$0.0312
Ownership
Direct
Form 4 holding Chief Financial Officer

RVL Pharmaceuticals plc

Security class
Ordinary Shares
Shares / value
22,852
Estimated value
$713
Report date
24 Jan 2022
Price
$0.0312
Ownership
By family limited liability company

Insider Reports Filed by Andrew J. Einhorn

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .